AIM Stock Analysis: Buy, Sell, or Hold?
AIM - AIM ImmunoTech Inc.
$0.62
0.11 (20.73%)
▲
5d:
-30.7%
30d:
+11.2%
90d:
-14.05%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AIM is down 30.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AIM is down 30.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.62, which is considered fair relative to its 30-day fair value range of $0.28 to $0.62.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $1.25. The stock is showing strong short-term momentum, up 20.7% recently.
Market Sentiment: AIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.25 (+917.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $1.25. The stock is showing strong short-term momentum, up 20.7% recently.
Market Sentiment: AIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.25 (+917.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.28 -
$0.62
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+20.7%)
- BULLISH: Trading 917.8% below Wall St target ($5.25)
- WARNING: Recommendation downgraded due to -30.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.28 -
$0.62
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.23
Resistance Level
$1.25
Current Trend
Strong Downtrend
Technical data as of
Jun 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.99
Wall Street Target
$5.25
(+917.8%)
Revenue Growth (YoY)
-53.3%
Share & Embed Analysis
Last updated: June 08, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
Data refreshes hourly during market hours. Next update: 12:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 57 HOLD |
